Markets

Genomic Health (GHDX) Shows Strength: Stock Gains 8.2%

An image of a pen on a stock chart
Credit: Shutterstock photo

Genomic Health Inc.GHDX was a big mover last session with its shares rising over 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past month's volatile price range of $28.61 to $30.80.

This healthcare laboratory service and research-based company has seen one downward estimate revision in the last 30 days. The Zacks Consensus Estimate has, however, remained unchanged over the same period. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Genomic Health currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the biomedical space may consider Baxalta Inc. BXLT which sports a Zacks Rank #1 (Strong Buy).

Is GHDX going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GENOMIC HEALTH (GHDX): Free Stock Analysis Report

BAXALTA INC (BXLT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More